Craving and personal functioning as mediators of extended-release buprenorphine efficacy: A four-way decomposition analysis from a randomised trial.

AddictionJul 1, 2026 (epub)
Clinical ResearchPsychiatry

John Marsden, Mike Kelleher, Fiona Cowden et al.

✦ AI-curated · Sources linked

In 30 seconds

This pre-registered exploratory causal mediation analysis examined whether reduced craving and improved personal functioning helped explain extended-release buprenorphine’s effect on opioid-free days. It used data from a 24-week, multicentre, open-label randomised trial of 314 adults with moderate-to-severe opioid use disorder, comparing extended-release buprenorphine with methadone or sublingual buprenorphine. During weeks 13–24, adjusted mean opioid-free days were 58.5 with extended-release buprenorphine and 48.9 with the comparator (IRR = 1.20, 95% CI = 1.10-1.30; P-value <0.001). Reduced opioid ‘need’ craving showed evidence of mediation; personal functioning did not clearly mediate benefit.

Key findings

  • Adjusted mean opioid-free days during weeks 13–24 were 58.5 with extended-release buprenorphine and 48.9 with methadone or sublingual buprenorphine (IRR = 1.20, 95% CI = 1.10-1.30; P-value <0.001).
  • Reduced opioid ‘need’ craving showed evidence of indirect mediation (PIE = 1.05, 95% CI = 1.01-1.10; P-value = 0.015).
  • Extended-release buprenorphine improved personal functioning (WSAS mean difference -3.79; P-value = 0.014), but WSAS did not clearly mediate treatment benefit (PIE = 1.05; P-value = 0.085).
  • Craving imagery and intrusiveness and opioid ‘want’ craving showed small, non-statistically significant indirect effects.

Why it matters

The analysis suggests that the benefit of extended-release buprenorphine on opioid-free days operated mainly through pathways not captured by the measured mediators, with reduced need-related craving a possible contributor. Distinguishing treatment outcomes from their potential mechanisms can help interpret pharmacotherapy trials and supports further study of need-related craving as a proximal mechanistic endpoint.

What to keep in mind

This was an exploratory secondary mediation analysis of a randomised trial. Craving was reduced to binary summaries of absence at all follow-up assessments versus presence at any assessment, and the findings do not establish mediation as a causal mechanism.

Source

Published in Addiction. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.